End-stage renal disease therapy: an American success story.
Friedman
E A
EA
Department of Medicine, State University of New York Health Science Center at Brooklyn, NY 11203, USA.
D003362:Cost-Benefit Analysis; D005060:Europe; D035082:Federal Government; D006801:Humans; D038622:Internationality; D007564:Japan; D007676:Kidney Failure, Chronic / Q000191:economics* / Q000401:mortality / Q000628:therapy*; D016030:Kidney Transplantation; D006278:Medicare / Q000458:organization & administration*; D018579:Patient Selection; D010530:Peritoneal Dialysis; D015397:Program Evaluation; D006435:Renal Dialysis; D017582:Renal Replacement Therapy / Q000191:economics* / Q000401:mortality / Q000706:statistics & numerical data; D040841:Resource Allocation; D014481:United States; D028761:Withholding Treatment